Literature DB >> 17597449

Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Davey M Smith1, Joseph K Wong, Hai Shao, George K Hightower, Stephanie H T Mai, Joseph M Moreno, Caroline C Ignacio, Simon D W Frost, Douglas D Richman, Susan J Little.   

Abstract

BACKGROUND: Transmitted drug-resistant HIV slowly reverts in the blood to drug-sensitive virus. The environment of the male genital tract (MGT) may result in even slower rates of reversion to drug susceptibility.
METHODS: We measured the decay of resistance in longitudinally collected blood and semen samples from 5 individuals newly infected with HIV containing resistance mutations to nonnucleoside reverse-transcriptase inhibitors (NNRTIs). We also investigated the sexual transmission of HIV to and from these participants.
RESULTS: In 3 of the 5 individuals, NNRTI resistance persisted in blood and semen throughout follow-up (mean, 296 days after the estimated day of infection [EDI]). In the other 2 individuals, NNRTI resistance persisted in blood and semen for 871 and 1179 days after the EDI; however, even after NNRTI resistance had fully reverted in blood, it remained readily detectable in semen. Two transmission groups were identified among these participants--one as the recipient partner and the other as the source partner.
CONCLUSIONS: Transmitted drug-resistant HIV, which persists in blood for years, may revert to wild type even more slowly in the MGT. This prolonged persistence in the MGT may contribute to the high prevalence rates of transmitted drug resistance.

Entities:  

Mesh:

Year:  2007        PMID: 17597449     DOI: 10.1086/519164

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  34 in total

1.  Patients infected with HIV type 1 subtype CRF01_AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine.

Authors:  Weerawat Manosuthi; David M Butler; Wasun Chantratita; Chonlaphat Sukasem; Douglas D Richman; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2010-06       Impact factor: 2.205

Review 2.  Minority variants of drug-resistant HIV.

Authors:  Sara Gianella; Douglas D Richman
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

3.  Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

Authors:  Matt A Price; Carole L Wallis; Shabir Lakhi; Etienne Karita; Anatoli Kamali; Omu Anzala; Eduard J Sanders; Linda-Gail Bekker; Rogers Twesigye; Eric Hunter; Pontiano Kaleebu; Kayitesi Kayitenkore; Susan Allen; Eugene Ruzagira; Mary Mwangome; Gaudensia Mutua; Pauli N Amornkul; Gwynn Stevens; Sergei L K Pond; Malinda Schaefer; Mary A Papathanasopoulos; Wendy Stevens; Jill Gilmour
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

4.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

5.  Transmitted resistance to HIV integrase strand-transfer inhibitors: right on schedule.

Authors:  Christopher B Hurt
Journal:  Antivir Ther       Date:  2011

6.  Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men.

Authors:  David M Butler; Davey M Smith; Edward R Cachay; George K Hightower; Charles Thomas Nugent; Douglas D Richman; Susan J Little
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

7.  HIV-1 Populations in Semen Arise through Multiple Mechanisms.

Authors:  Jeffrey A Anderson; Li-Hua Ping; Oliver Dibben; Cassandra B Jabara; Leslie Arney; Laura Kincer; Yuyang Tang; Marcia Hobbs; Irving Hoffman; Peter Kazembe; Corbin D Jones; Persephone Borrow; Susan Fiscus; Myron S Cohen; Ronald Swanstrom
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

8.  Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Authors:  Susan J Little; Simon D W Frost; Joseph K Wong; Davey M Smith; Sergei L Kosakovsky Pond; Caroline C Ignacio; Neil T Parkin; Christos J Petropoulos; Douglas D Richman
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

9.  Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.

Authors:  George K Hightower; Scott L Letendre; Mariana Cherner; Sarah A Gibson; Ronald J Ellis; Tanya J Wolfson; Anthony C Gamst; Caroline C Ignacio; Robert K Heaton; Igor Grant; Douglas D Richman; Davey M Smith
Journal:  Virology       Date:  2009-09-16       Impact factor: 3.616

10.  Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy.

Authors:  Libin Rong; Alan S Perelson
Journal:  PLoS Comput Biol       Date:  2009-10-16       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.